LifeSpan Licenses DrugTarget Database to Undisclosed Pharma

NEW YORK, Aug. 23 (GenomeWeb News) - LifeSpan BioSciences said today that it has licensed its DrugTarget database to an undisclosed pharmaceutical company, marking the 50th database license the company has issued.

According to the company, the database contains proprietary human protein localization data for drug targets in eight gene families, including G protein-coupled receptors, nuclear hormone receptors, kinases, ion channels, phosphatases, proteases, phosphodiesterases, and transporters.

Under the new licensing agreement, the subscriber will nominate 50 additional genes for study and inclusion in the expanded database over a two-year period. It already includes 822 immunohistochemistry reports with localization information on more than 400 potential drug target genes selected by subscribers, said LifeSpan. The expanded database will include ion channels, secreted proteins, phosphatases, and other families of genes.

Additional terms of the license were not disclosed.